Cipla on Friday said a routine US Food and Drug Administration (USFDA) inspection at its wholly owned subsidiary InvaGen Pharmaceuticals' manufacturing facility in Hauppauge, Long Island, New York.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BoM65tl
via IFTTT
-
India's Syngene International has agreed to acquire its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 milli...
-
The establishment inspection report (EIR) was issued after the last inspection of the facility conducted from October 17-29, 2022, the compa...
-
Connecticut or Delaware or Florida from Bodybuilding.com Forums - Nutrition https://ift.tt/rq4G6m2
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2026
(678)
-
▼
October
(50)
- Cipla subsidiary clears USFDA inspection with zero...
- At 22, he built a gym machine in his garage. Now, ...
- Cancer drugs to get cheaper? Here’s what the lates...
- From Continuous Data to Trusted Health Intelligenc...
- Sanofi healthcare receives CDSCO approval for Qfti...
- Dr Reddy's gets DCGI nod for Zytorvi in advanced e...
- HealthRail: Turning India's hospital receivables i...
- NATCO Pharma subsidiary launches Carboplatin in US...
- AIIMS doctors identify ‘Red Alert Zone’ to reduce ...
- The burden of cancer drugs: Millions battle exorbi...
- Aayush Wellness launches calcium, vitamin suppleme...
- NPPA caps trade margins on 137 cancer drugs at 30%...
- Shridevi Institute, US-based Vaxonyx sign MoU for ...
- NITI Aayog explores policies to boost India's medi...
- HLL Lifecare launches eStore to expand direct-to-c...
- AYUSH sees rise in patents filings showcasing inno...
- India needs 2.6 billion sq ft of healthcare space ...
- Indian, German firms to collaborate on immunoglobu...
- Biocon settles US patent dispute with Roche's Gene...
- Novo Holdings, GIC, Axight look to back AIG Hospit...
- Health ministry asked to examine coronary stent sa...
- Biocon clears path for cancer drug launch
- NMC Healthcare founder BR Shetty files $15 billion...
- Biocon founder Kiran Mazumdar Shaw says India must...
- Zydus moves closer to US market for Keytruda biosi...
- Panel to finalise cancer drugs for 30% trade margi...
- Supreme Court questions govt over drug pricing, as...
- Joint pain isn’t the same for everyone. Should tre...
- Roche calls for global healthcare overhaul to tack...
- Tricog Health targets 100 million cardiac screenin...
- Indian pharma's risk aversion holding back innovat...
- Health ministry proposes curbs on prescription dru...
- Experiments on animals set to become easier
- Hair fall decoded: Causes, triggers, and warning s...
- National Medical Commission bans doctors & hospita...
- Govt set to cap trade margins on more cancer drugs...
- Supreme Court seeks committee to curb pharma firms...
- Ayush services sector supports 1.76 million liveli...
- The 30-Minute Medicine Problem
- Drug panel rejects child images on cough syrup lab...
- Lord’s Mark strengthens UK and UK allied market st...
- Centre may seek legal view on licensing of sterile...
- Ayush services sector supports 1.76 million liveli...
- Wall Street’s $10 billion India hospital bet spark...
- Robotic surgery gains rapid ground in India, Delhi...
- Maharashtra FDA cancels Cipla's Pune warehouse lic...
- India has biotech talent and know-how, but funding...
- ‘India’s biotech ecosystem holds tremendous promis...
- Karnataka flags 52x mark-up on cancer drugs, seeks...
- Rasayan Labs launches AI-native drug discovery pla...
-
▼
October
(50)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment